A less invasive procedure to reduce the risk of stroke by clearing blockages of the carotid artery in the neck is being offered more widely as a result of recent approval by the Food & Drug Administration.
The procedure, called transcarotid artery revascularization, or TCAR, employs the unusual technique of temporarily reversing the flow of blood away from the brain in order to reduce the risk of stroke during and after the surgery.
Previously, this relatively new endovascular approach was reserved by the FDA for only a small subset of patients. However, several years of data has shown it is as safe and successful as the more traditional endarterectomy “open surgery,” while also offering the benefits of a quicker recovery, smaller incision and reduced risk of nerve injury.
Read More: https://baptisthealth.net/baptist-health-news/going-against-the-flow-innovative-tcar-procedure-lowers-stroke-risk/
|
Comments are closed.
|
Archives
December 2020
|
RSS Feed
